Clinical Trial Update: Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and tolerability of inhaled lucinactant in premature neonates with respiratory distress syndrome; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Lucinactant (lucinactant)

Snippet

Sponsor: Windtree Therapeutics | Conditions: Respiratory Distress Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-04-21